West Pharmaceutical Services, Inc. (WST)
West Pharmaceutical Services, Inc. Income Statement 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenue | 3.07B | 2.89B | 2.95B | 2.89B | 2.83B | 2.15B | 1.84B | 1.72B | 1.60B | 1.51B | 1.40B | 1.42B | 1.37B | 1.27B | 1.19B | 1.10B | 1.06B | 1.05B |
| Gross Profit | 1.10B | 998.5M | 1.13B | 1.14B | 1.18B | 767.8M | 605.7M | 545.4M | 512.9M | 501.4M | 455.8M | 447.8M | 434.7M | 387.7M | 339.3M | 318.1M | 303.6M | 302.6M |
| Profitability | ||||||||||||||||||
| Operating Income | 584.9M | 569.9M | 676.0M | 734.0M | 752.3M | 406.9M | 296.6M | 240.3M | 225.8M | 195.2M | 128.6M | 182.0M | 162.4M | 135.1M | 109.6M | 90.7M | 97.5M | 124.1M |
| EBITDA | 756.3M | 725.3M | 813.3M | 854.6M | 874.6M | 516.0M | 400.0M | 344.7M | 322.5M | 285.9M | 218.5M | 272.0M | 247.6M | 212.0M | 185.3M | 163.9M | 165.6M | — |
| Net Income | 493.7M | 492.7M | 593.4M | 585.9M | 661.8M | 346.2M | 241.7M | 206.9M | — | — | — | — | — | — | — | 65.3M | 72.6M | 86.0M |
| Per Share Data | ||||||||||||||||||
| EPS (diluted) | $6.79 | $6.69 | $7.88 | $7.73 | $8.67 | $4.57 | $3.21 | $2.74 | $1.99 | $1.91 | $1.30 | $1.75 | $1.57 | $1.15 | $1.08 | $1.89 | $2.12 | $2.50 |
| Shares Outstanding (dil.) | 73M | 74M | 75M | 76M | 76M | 76M | 75M | 75M | 76M | 75M | 74M | 73M | 71M | 72M | 74M | 37M | 36M | 36M |
West Pharmaceutical Services, Inc. Income Statement — FAQ
West Pharmaceutical Services, Inc. (WST) income statement over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WST's income statement history?
The chart and table above show West Pharmaceutical Services, Inc.'s income statement by year and by quarter, including the growth rate.